AAAAAA

   
Results: 1-17 |
Results: 17
Changes in metabolic parameters and body shape after replacement of protease inhibitor with efavirenz in virologically controlled HIV-1-positive persons: Single-arm observational cohort
Authors: Moyle, G Baldwin, C Mandalia, S Comitis, S Burn, P Gazzard, B
Citation: G. Moyle et al., Changes in metabolic parameters and body shape after replacement of protease inhibitor with efavirenz in virologically controlled HIV-1-positive persons: Single-arm observational cohort, J ACQ IMM D, 28(4), 2001, pp. 399-401
Comparison of virologic, immunologic, and clinical response to five different initial protease inhibitor-containing and nevirapine-containing regimens
Authors: Easterbrook, PJ Newson, R Ives, N Pereira, S Moyle, G Gazzard, BG
Citation: Pj. Easterbrook et al., Comparison of virologic, immunologic, and clinical response to five different initial protease inhibitor-containing and nevirapine-containing regimens, J ACQ IMM D, 27(4), 2001, pp. 350-364
Searching for solutions: the African crisis and the need for safe, simple and cheap prevention and therapy
Authors: Moyle, G
Citation: G. Moyle, Searching for solutions: the African crisis and the need for safe, simple and cheap prevention and therapy, CURR OPIN I, 14(1), 2001, pp. 1-3
Mitochondrial toxicity hypothesis for lipoatrophy: a refutation
Authors: Moyle, G
Citation: G. Moyle, Mitochondrial toxicity hypothesis for lipoatrophy: a refutation, AIDS, 15(3), 2001, pp. 413-415
Antiretroviral therapy for HIV-2 infected patients
Authors: Smith, NA Shaw, T Berry, N Vella, C Okorafor, L Taylor, D Ainsworth, J Choudhury, A Daniels, RS El-Gadi, S Fakoya, A Moyle, G Oxford, J Tedder, R O'Shea, S de Ruiter, A Breuer, J
Citation: Na. Smith et al., Antiretroviral therapy for HIV-2 infected patients, J INFECTION, 42(2), 2001, pp. 126-133
The steady-state pharmacokinetics of efavirenz and nevirapine when used incombination in human immunodeficiency virus type 1-infected persons
Authors: Veldkamp, AI Harris, M Montaner, JSG Moyle, G Gazzard, B Youle, M Johnson, M Kwakkelstein, MO Carlier, H van Leeuwen, R Beijnen, JH Lange, JMA Reiss, P Hoetelmans, RMW
Citation: Ai. Veldkamp et al., The steady-state pharmacokinetics of efavirenz and nevirapine when used incombination in human immunodeficiency virus type 1-infected persons, J INFEC DIS, 184(1), 2001, pp. 37-42
The emerging roles of non-nucleoside reverse transcriptase inhibitors in antiretroviral therapy
Authors: Moyle, G
Citation: G. Moyle, The emerging roles of non-nucleoside reverse transcriptase inhibitors in antiretroviral therapy, DRUGS, 61(1), 2001, pp. 19-26
The SPICE study: 48-week activity of combinations of saquinavir soft gelatin and nelfinavir with and without nucleoside analogues
Authors: Moyle, G Pozniak, A Opravil, M Clumeck, N DelFraissy, JF Johnson, M Pelgrom, J Reynes, J Vittecoq, D DeLora, P Salgo, M Duff, F
Citation: G. Moyle et al., The SPICE study: 48-week activity of combinations of saquinavir soft gelatin and nelfinavir with and without nucleoside analogues, J ACQ IMM D, 23(2), 2000, pp. 128-137
Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy
Authors: Sharkey, ME Teo, I Greenough, T Sharova, N Luzuriaga, K Sullivan, JL Bucy, RP Kostrikis, LG Haase, A Veryard, C Davaro, RE Cheeseman, SH Daly, JS Bova, C Ellison, RT Mady, B Lai, KK Moyle, G Nelson, M Gazzard, B Shaunak, S Stevenson, M
Citation: Me. Sharkey et al., Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy, NAT MED, 6(1), 2000, pp. 76-81
Clinical manifestations and management of antiretroviral nucleoside analog-related mitochondrial toxicity
Authors: Moyle, G
Citation: G. Moyle, Clinical manifestations and management of antiretroviral nucleoside analog-related mitochondrial toxicity, CLIN THER, 22(8), 2000, pp. 911-936
Toxicity of antiretroviral nucleoside and nucleotide analogues - Is mitochondrial toxicity the only mechanism?
Authors: Moyle, G
Citation: G. Moyle, Toxicity of antiretroviral nucleoside and nucleotide analogues - Is mitochondrial toxicity the only mechanism?, DRUG SAFETY, 23(6), 2000, pp. 467-481
Efavirenz: practicalities, considerations and new issues
Authors: Moyle, G
Citation: G. Moyle, Efavirenz: practicalities, considerations and new issues, INT J CL PR, 1999, pp. 30-34
Poor reduction of HIV-1 RNA titres in nucleoside reverse transcriptase inhibitor experienced patients treated with indinavir combination therapy
Authors: Ball, JK Rowe, T Curran, R Irving, WL Beards, GM Sontag, G Youle, M Moyle, G Pillay, D
Citation: Jk. Ball et al., Poor reduction of HIV-1 RNA titres in nucleoside reverse transcriptase inhibitor experienced patients treated with indinavir combination therapy, SEX TRANS I, 75(5), 1999, pp. 337-339
Commentary: Resistance testing - a clinical perspective
Authors: Gazzard, BG Moyle, G
Citation: Bg. Gazzard et G. Moyle, Commentary: Resistance testing - a clinical perspective, SEX TRANS I, 75(3), 1999, pp. 141-142
Treatment guidelines and clinical realities
Authors: Moyle, G
Citation: G. Moyle, Treatment guidelines and clinical realities, CURR OPIN I, 12(1), 1999, pp. 1-3
Occurrence of an environmental estrogen (4-nonylphenol) in sewage treatment plant effluent and the aquatic receiving environment
Authors: Sekela, M Brewer, R Moyle, G Tuominen, T
Citation: M. Sekela et al., Occurrence of an environmental estrogen (4-nonylphenol) in sewage treatment plant effluent and the aquatic receiving environment, WATER SCI T, 39(10-11), 1999, pp. 217-220
Quality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine, and saquinavir-zalcitabine-zidovudine therapy for HIV-infectedadults with CD4 cell counts between 50 and 350 per cubic millimeter
Authors: Revicki, DA Moyle, G Stellbrink, HJ Barker, C
Citation: Da. Revicki et al., Quality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine, and saquinavir-zalcitabine-zidovudine therapy for HIV-infectedadults with CD4 cell counts between 50 and 350 per cubic millimeter, AIDS, 13(7), 1999, pp. 851-858
Risultati: 1-17 |